Document Classification

Section Type: RESULTS

Text: Overall, risk of adverse events (3. 9 %) and mortality (0. 65 %) was low for patients with CURB65 score 0-1 and ProADM 0. 75 nmol/l (CURB65-A risk class I) ; intermediate (8. 6 % and 2. 6 %, respectively) for patients with CURB65 score of 2 and ProADM 1. 5 nmol/l or CURB classes 0-1 and ProADM levels between 0. 75-1. 5 nmol/L (CURB65-A risk class II), and high (21. 6 % and 9. 8 %, respectively) for all other patients (CURB65-A risk class III).